Next-gen VC. The co-founder of mySugr launches 1921 VC — €50M for HealthTech, Climate, and AI.
Fredrik Debong, one of the founders of the well-known HealthTech startup mySugr (acquired by Roche), has launched the venture fund 1921 VC with €50 million under management. But this is more than just a fund — it’s a platform for conscious venture capital, focused on investing in technologies that deliver long-term positive impact.
1921 VC focuses on three sectors shaping the future:
— HealthTech: digital healthcare, preventive models, bioinformatics.
— ClimateTech: decarbonization, green energy, sustainable materials.
— AI: infrastructure, generative models, AI-driven science and industry.
What makes the fund different is that it doesn’t just write checks — it actively supports operational growth, regulatory compliance, certification, international expansion, and scaling tech teams.
According to Debong, the goal is to invest in startups that will truly change the biosphere, economy, and quality of life by 2050.
This new wave of venture capital is not about aggressive growth at any cost. It’s about capital that creates systemic change.
👉 Learn more: https://1921.vc
